Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Journal of Thrombosis and Haemostasis : JTH|April 17, 2020
SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosisJulia Tilburg, Daniëlle M Coenen, Gaia Zirka, et al.
International Journal of Cancer|December 27, 2019
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy populationSushil K Badrising, Rebecca D Louhanepessy, Vincent van der Noort, et al.
Genes and Immunity|May 4, 2012
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosisC McKinney, J C A Broen, M C Vonk, et al.
International Journal of Cancer|September 23, 2014
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxelMichel D Wissing, Jules L L M Coenen, Pieter van den Berg, et al.
Scientific Reports|November 10, 2020
Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid arteryT G Mastenbroek, M F A Karel, M Nagy, et al.
Oncology|August 22, 2016
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate CancerSushil K Badrising, Vincent van der Noort, Paul Hamberg, et al.
Eclinicalmedicine|April 25, 2022
Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the NetherlandsHannah G Juncker, Sien J Mulleners, Eliza J M Ruhé, et al.
The Prostate|September 23, 2015
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relationSushil K Badrising, Vincent van der Noort, Alfons J M van den Eertwegh, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world populationH M Westgeest, M C P Kuppen, A J M van den Eertwegh, et al.
Prostate Cancer and Prostatic Diseases|August 27, 2021
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223Sushil K Badrising, Rebecca D Louhanepessy, Vincent van der Noort, et al.
Pageof 22